As a potential regulatory mechanism that promotes ER dependency for cell proliferation and survival in ER+ breast cancer cells, receptor tyrosine kinases (RTKs), such as EGFR and IGF1R, and their associated ligands, including IRS2, are putative targets of miR-7 [8, 54–56]. Here, ESR1 is linked to breast cancer.